| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/17/2005 | CN1654657A Novel streptococcus antigens |
| 08/17/2005 | CN1654064A Chinese medicinal composition for treating respiratory illness and digestive illness |
| 08/17/2005 | CN1654043A Method for preparing pure Chinese medicinal single prescription aqua agent and use thereof |
| 08/17/2005 | CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin |
| 08/17/2005 | CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/17/2005 | CN1214817C Coupling factor 6 inhibitor and potentiator and use thereof |
| 08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
| 08/16/2005 | US6930188 Stable hydrate of a muscarinic receptor antagonist |
| 08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
| 08/16/2005 | US6930118 3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 08/16/2005 | US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |
| 08/16/2005 | US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders |
| 08/16/2005 | US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders |
| 08/16/2005 | US6930100 Phosphate prodrugs of fluoroxindoles |
| 08/16/2005 | US6930085 G-type peptides to ameliorate atherosclerosis |
| 08/16/2005 | US6929798 Compositions and methods for treatment of microbial infections |
| 08/16/2005 | CA2335363C Adhesively applied external nasal strips and dilators containing medications and fragrances |
| 08/16/2005 | CA2236164C Pulmonary surfactant peptide solubilization process |
| 08/16/2005 | CA2166059C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/11/2005 | WO2005041858A3 Mucin production inhibitor |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176931 Eotaxin : eosinophil chemotactic cytokine |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis |
| 08/11/2005 | US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders |
| 08/11/2005 | US20050176815 Malaria therapy |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176800 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 08/11/2005 | US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis |
| 08/11/2005 | US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/11/2005 | US20050176780 2,5-disubstituted 3-mercaptopentanoic acid |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176751 Selective H1 histamine receptor antagonists; bronchial asthma, allergic rhinitis, conjunctivitis, dermatitis, urticaria and other allergic diseases; e.g. 3-(4-[1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]piperidin-1-ylmethyl)benzoic acid |
| 08/11/2005 | US20050176747 hypertension and asthma; vasorelaxants |
| 08/11/2005 | US20050176732 Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 08/11/2005 | US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof |
| 08/11/2005 | US20050176694 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 08/11/2005 | US20050176687 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 08/11/2005 | US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs |
| 08/11/2005 | US20050176631 Method for reducing morbidity and mortality in critically ill patients |
| 08/11/2005 | US20050176625 Synthetic lipid mixtures for the preparation of a reconstituted surfactant |
| 08/11/2005 | US20050175639 Methods |
| 08/11/2005 | US20050175628 Chinese herb medicine composition in the form of jelly |
| 08/11/2005 | DE202005007671U1 Beeswax compress, useful for treating pain or coughing or for immune stimulation, comprises fatty or ethereal oils |
| 08/11/2005 | DE202005004661U1 Composition containing tiotropium, useful for treatment of respiratory diseases by inhalation, comprises a dry powder filled directly into a sealed container |
| 08/11/2005 | CA2554064A1 Treatment methods |
| 08/11/2005 | CA2553089A1 Novel piperidines as chemokine modulators (ccr) |
| 08/10/2005 | EP1561751A1 Fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals |
| 08/10/2005 | EP1561463A2 Benzamidoxime prodrugs as antipneumocystic agents |
| 08/10/2005 | EP1560828A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 08/10/2005 | EP1560592A1 Treatment of hypersensitivity conditions |
| 08/10/2005 | EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 08/10/2005 | EP1507514A4 Controlled release compositions of estradiol metabolites |
| 08/10/2005 | EP1471919B1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist |
| 08/10/2005 | EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors |
| 08/10/2005 | EP1343826B1 Polysaccharide compound having immune stimulating activity |
| 08/10/2005 | EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 08/10/2005 | EP1301207B1 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin |
| 08/10/2005 | EP1208103B1 Reverse-turn mimetics and methods relating thereto |
| 08/10/2005 | EP1194425B1 Substituted benzimidazole |
| 08/10/2005 | EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 08/10/2005 | CN1653089A Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 08/10/2005 | CN1653088A Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant |
| 08/10/2005 | CN1653068A Novel diazabicyclic biaryl derivatives |
| 08/10/2005 | CN1653059A Macrocyclic compounds useful as pharmaceuticals |
| 08/10/2005 | CN1653050A Opioid and opioid-like compounds and uses thereof |
| 08/10/2005 | CN1653047A Monocyclic aroylpyridinones as antiinflammatory agents |
| 08/10/2005 | CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 08/10/2005 | CN1653025A NK1 antagonists |
| 08/10/2005 | CN1652843A Methods for the treatment of respiratory diseases and conditions using a selective iNOS inhibitor |
| 08/10/2005 | CN1652822A New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders |
| 08/10/2005 | CN1652820A Methods of treatment using CTLA-4 antibodies |
| 08/10/2005 | CN1652814A Induction of antigen specific immunologic tolerance |
| 08/10/2005 | CN1652805A An herbal composition for the treatment and remedy of bronchial respiratory difficulties |
| 08/10/2005 | CN1652800A Remedies for lung cancer |
| 08/10/2005 | CN1652795A Compositions and methods for treating emphysema |
| 08/10/2005 | CN1652783A Compositions and method for treating infection in cattle and swine |
| 08/10/2005 | CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors |
| 08/10/2005 | CN1652779A Treatment of chemokine mediated diseases |
| 08/10/2005 | CN1652772A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione: methods of using and compositions thereof |
| 08/10/2005 | CN1652769A Phosphate prodrugs of fluorooxindoles |
| 08/10/2005 | CN1652762A Anti-rhinovirus active agents |
| 08/10/2005 | CN1652756A Matrix type patch containing bronchodilators |
| 08/10/2005 | CN1652687A Choline-silicic acid complex with osmolytes and divalent trace elements |
| 08/10/2005 | CN1651465A Glycosyl modified dietary fiber, its preparation method and application |
| 08/10/2005 | CN1651432A Method of refining plamatine from herba fibranreae recisae total ulkuloid and its application |
| 08/10/2005 | CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/10/2005 | CN1651423A Felt wort extract, its preparation method and use |
| 08/10/2005 | CN1651395A Borneol fatly acid ester derivative and preparation containing said derivative |
| 08/10/2005 | CN1651066A Notoginseng throat nourishing lozenge and its preparation method |
| 08/10/2005 | CN1651057A Cinnamon poria capsule and its preparation process |
| 08/10/2005 | CN1651032A Chinese medicinal composition for clearing heat and stopping cough, and its preparation method |
| 08/10/2005 | CN1651031A Double coptis root effervescent tablet and its preparation method |
| 08/10/2005 | CN1651022A Xinxue capsule and its preparation technology |
| 08/10/2005 | CN1651020A Northern bean root soft capsule and its preparation process |